Cholesteotoma a new experimental animal model (2005)
- Authors:
- USP affiliated authors: ISAAC, MYRIAM DE LIMA - FMRP ; OLIVEIRA, JOSE ANTONIO APPARECIDO DE - FMRP ; FERES, MARIA CRISTINA LANCIA CURY - FMRP
- Unidade: FMRP
- Assunto: OTORRINOLARINGOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: World Congress of The International Federation of Otorhinolaryngological Societies
-
ABNT
MASSUDA, Eduardo Tanaka et al. Cholesteotoma a new experimental animal model. 2005, Anais.. Rome: IFOS, 2005. . Acesso em: 17 jun. 2025. -
APA
Massuda, E. T., Oliveira, J. A. A. de, Isaac, M. de L., & Féres, M. C. L. C. (2005). Cholesteotoma a new experimental animal model. In Abstracts. Rome: IFOS. -
NLM
Massuda ET, Oliveira JAA de, Isaac M de L, Féres MCLC. Cholesteotoma a new experimental animal model. Abstracts. 2005 ;[citado 2025 jun. 17 ] -
Vancouver
Massuda ET, Oliveira JAA de, Isaac M de L, Féres MCLC. Cholesteotoma a new experimental animal model. Abstracts. 2005 ;[citado 2025 jun. 17 ] - Application of gentamicyn in the middle ear for unilateral vestibular ablation in guinea pigs
- Tonturas como manifestação de meningeomas
- Application of gentamicyn in the middle for unilateral vestibular ablation in guinea pigs
- Cross defense of auditory hair cells to toxic levels of gentamicin throught a preveously exposure to non toxic levels of amicacin
- Cholesteatoma a new experimental animal model
- Cross defense of auditory hair cells to toxic levels of gentamicin throught a preveously exposure to non toxic levels of amicacin
- Amifostine, otoprotection to cisplatin ototoxycity: a guinea pig study using otoacoustic emissions distortion products (DPOEA) and scanning microscopy
- Zumbido em paciente com megadolicobasilar: relato de caso
- Amifostine otoprotection to cisplatin ototoxycity: a guinea pig study using otoacoustic emissions-distortion products (DPOEA) and scanning microscopy
- Tinnitus as a manifestation of a cerebellopontine angle lipoma
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
